Orion Infusions (DHA:ORIONINFU) Total Assets : BDT844.1 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Total Assets?

Orion Infusions's Total Assets for the quarter that ended in Dec. 2024 was BDT844.1 Mil.

During the past 12 months, Orion Infusions's average Total Assets Growth Rate was 2.30% per year. During the past 3 years, the average Total Assets Growth Rate was 6.40% per year. During the past 5 years, the average Total Assets Growth Rate was 4.10% per year. During the past 10 years, the average Total Assets Growth Rate was 1.00% per year.

During the past 13 years, Orion Infusions's highest 3-Year average Total Assets Growth Rate was 6.40%. The lowest was -2.00%. And the median was 0.50%.

Total Assets is connected with ROA %. Orion Infusions's annualized ROA % for the quarter that ended in Dec. 2024 was 4.76%. Total Assets is also linked to Revenue through Asset Turnover. Orion Infusions's Asset Turnover for the quarter that ended in Dec. 2024 was 0.23.

Orion Infusions Total Assets Historical Data

The historical data trend for Orion Infusions's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Total Assets Chart

Orion Infusions Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Assets

Get a 7-Day Free Trial

698.40

675.80

755.20

836.70

824.74

Orion Infusions Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															828.75	796.01	824.74	825.31	844.12

Orion Infusions Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Orion Infusions's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (A: Jun. 2024 )	+	Total Liabilities (A: Jun. 2024 )
	=	314.624	+	510.12
	=	824.7

Orion Infusions's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	312.083	+	532.033
	=	844.1

Orion Infusions (DHA:ORIONINFU) Total Assets Explanation

Total Assets is connected with ROA %.

Orion Infusions's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	39.772	/	( (825.307	+	844.116)	/ 2 )
	=	39.772	/	834.7115
	=	4.76 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Orion Infusions's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	195.047	/	( (825.307	+	844.116)	/ 2 )
=	195.047	/	834.7115
=	0.23

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Orion Infusions Total Assets Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions Headlines

No Headlines